ESSA Pharma (EPIX) has the following price history information. Looking back at EPIX historical stock prices for the last five trading days, on April 23, 2024, EPIX opened at $6.46, traded as high as $7.25 and as low as $6.40, and closed at $6.40. Trading volume was a total of 130.50K shares. On April 24, 2024, EPIX opened at $6.47, traded as high as $6.56 and as low as $6.25, and closed at $6.25. Trading volume was a total of 41.30K shares. On April 25, 2024, EPIX opened at $6.18, traded as high as $6.48 and as low as $5.92, and closed at $6.12. Trading volume was a total of 64.80K shares. On April 26, 2024, EPIX opened at $6.12, traded as high as $6.22 and as low as $5.71, and closed at $6.08. Trading volume was a total of 178.50K shares. On April 29, 2024, EPIX opened at $6.08, traded as high as $6.21 and as low as $5.55, and closed at $6.14. Trading volume was a total of 147.50K shares.

EPIX Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 20142015201620172018201920202021202220232024

Below, we examine the compound annual growth rate — CAGR for short — of an investment into ESSA Pharma shares, starting with a $10,000 purchase of EPIX, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	03/16/2015
End date:	04/29/2024
Start price/share:	$4.39
End price/share:	$6.14
Dividends collected/share:	$0.00
Total return:	39.86%
Average Annual Total Return:	3.74%
Starting investment:	$10,000.00
Ending investment:	$13,982.01
Years:	9.13

EPIX Historical Price Range
Date	Open	High	Low	Close	Volume
04/23/2024	$6.46	$7.25	$6.40	$6.40	130.50K
04/24/2024	$6.47	$6.56	$6.25	$6.25	41.30K
04/25/2024	$6.18	$6.48	$5.92	$6.12	64.80K
04/26/2024	$6.12	$6.22	$5.71	$6.08	178.50K
04/29/2024	$6.08	$6.21	$5.55	$6.14	147.50K

About ESSA Pharma

ESSA Pharma is a clinical stage pharmaceutical company. Co. is focused on developing therapies for the treatment of prostate cancer in patients whose disease is progressing despite treatment with care therapies, including anti-androgen drugs such as abiraterone, enzalutamide, apalutamide, and darolutamide. Co.'s series of investigational compounds, including its product candidate EPI-7386, is used in patients with castration-resistant prostate cancer through anti-hormone-based therapies. The compounds are designed to disrupt the androgen receptor (AR) signaling pathway and prevent AR activation through selective binding to the N-terminal domain of the AR.

EPIX Historical Closing Prices
Date	Close
04/23/2024	$6.40
04/24/2024	$6.25
04/25/2024	$6.12
04/26/2024	$6.08
04/29/2024	$6.14

EPIX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.